Lombardia Capital Partners’s Pfizer PFE Stock Holding History

Lombardia Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,345	Closed	-$279K	–	193
2016 Q2	$279K	Hold	8,345	–	–	0.02%	180
2016 Q1	$235K	Hold	8,345	–	–	0.01%	204
2015 Q4	$256K	Hold	8,345	–	–	0.01%	191
2015 Q3	$249K	Hold	8,345	–	–	0.01%	183
2015 Q2	$265K	Sell	8,345 -304,539	-97%	-$9.93M	0.01%	198
2015 Q1	$10.3M	Sell	312,884 -93,832	-23%	-$2.98M	0.31%	121
2014 Q4	$12M	Sell	406,716 -44,098	-10%	-$1.26M	0.35%	119
2014 Q3	$12.6M	Buy	450,814 +54,660	+14%	+$1.53M	0.37%	115
2014 Q2	$11.2M	Sell	396,154 -46,246	-10%	-$1.32M	0.3%	122
2014 Q1	$13.5M	Buy	442,400 +18,508	+4%	+$552K	0.37%	102
2013 Q4	$12.3M	Sell	423,892 -4,263	-1%	-$124K	0.35%	104
2013 Q3	$11.7M	Buy	428,155 +316	+0.1%	+$8.6K	0.38%	95
2013 Q2	$11.4M	Buy	+427,839	New	+$11.8M	0.38%	95

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lombardia Capital Partners's PFE Position: Q3 2016 in Review

Lombardia Capital Partners sold out of Pfizer (PFE) in Q3 2016, closing a stake of 8,345 shares — an estimated $279K sold.

Lombardia Capital Partners first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $13.5M in Q1 2014. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Lombardia Capital Partners reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Lombardia Capital Partners sold 8,345 Pfizer shares in Q3 2016, an estimated $279K.
Lombardia Capital Partners first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
Lombardia Capital Partners's Pfizer position peaked at $13.5M in Q1 2014.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Lombardia Capital Partners's 13F filing for Q3 2016, filed 9 Nov 2016.